<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">medsovet</journal-id><journal-title-group><journal-title xml:lang="ru">Медицинский Совет</journal-title><trans-title-group xml:lang="en"><trans-title>Meditsinskiy sovet = Medical Council</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2079-701X</issn><issn pub-type="epub">2658-5790</issn><publisher><publisher-name>REMEDIUM GROUP Ltd.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.21518/2079-701X-2020-15-90-95</article-id><article-id custom-type="elpub" pub-id-type="custom">medsovet-5831</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ЗАБОЛЕВАНИЯ ПЕЧЕНИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>LIVER DISEASE</subject></subj-group></article-categories><title-group><article-title>Дисфункция сфинктера Одди в постхолецистэктомическом периоде</article-title><trans-title-group xml:lang="en"><trans-title>Sphincter of Oddi dysfunction in the post-cholecystectomy period</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5041-3466</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Буеверов</surname><given-names>А. О.</given-names></name><name name-style="western" xml:lang="en"><surname>Bueverov</surname><given-names>A. О.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Буеверов Алексей Олегович, доктор медицинских наук, профессор кафедры медико-социальной экспертизы, неотложной и поликлинической терапии Института профессионального образования, Федеральное государственное автономное образовательное учреждение высшего образования «Первый Московский государственный медицинский университет им. И.М. Сеченова» Министерства здравоохранения Российской Федерации (Сеченовский Университет); ведущий научный сотрудник отделения гепатологии, Государственное бюджетное учреждение здравоохранения Московской области «Московский областной научно-исследовательский клинический институт им. М. Ф. Владимирского»</p><p>119991, Москва, ул. Трубецкая, д. 8, стр. 2, </p><p>129110, Москва, ул. Щепкина, д. 61/2, корп. 1 </p></bio><bio xml:lang="en"><p>Alexey O. Bueverov, Dr. of Sci. (Med.), Professor, Department of Medical and Social Expertise, Emergency and Outpatient Therapy, Institute of Professional Education, Federal State Autonomous Educational Institution of Higher Education “I.M. Sechenov First Moscow State Medical University” of the Ministry of Health of the Russian Federation (Sechenov University); Lead Researcher, Department of Hepatology, State Budgetary Institution of Healthcare of Moscow Region “Moscow Regional Research Clinical Institute named after M.F. Vladimirsky”</p><p>8, Bldg. 2, Trubetskaya St., Moscow, 119991, </p><p>Bldg. 1, 61/2, Schepkin St., Moscow, 129110</p></bio><email xlink:type="simple">bcl72@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Первый Московский государственный медицинский университет им. И.М. Сеченова (Сеченовский Университет);&#13;
Московский областной научно-исследовательский клинический институт им. М.Ф. Владимирского</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Sechenov First Moscow State Medical University (Sechenov University);&#13;
Moscow Regional Research Clinical Institute named after M.F. Vladimirsky</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2020</year></pub-date><pub-date pub-type="epub"><day>22</day><month>10</month><year>2020</year></pub-date><volume>0</volume><issue>15</issue><fpage>90</fpage><lpage>95</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Буеверов А.О., 2020</copyright-statement><copyright-year>2020</copyright-year><copyright-holder xml:lang="ru">Буеверов А.О.</copyright-holder><copyright-holder xml:lang="en">Bueverov A.О.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.med-sovet.pro/jour/article/view/5831">https://www.med-sovet.pro/jour/article/view/5831</self-uri><abstract><p>Причины персистирования симптоматики после холецистэктомии (ХЭ) могут быть разделены на четыре группы: 1) погрешности операции; 2) рецидив холелитиаза; 3) функциональные нарушения, обусловленные удалением желчного пузыря (транзиторные либо персистирующие); 4) патология, не связанная с ХЭ. У 20–40% пациентов после ХЭ сохраняется билиарная боль, в большинстве случаев обусловленная дисфункцией сфинктера Одди (ДСО).ДСО подразделяется на билиарный, панкреатический, двупротоковый типы, а также панкреато-билиарный рефлюкс. В основе ДСО лежит повышение давления в сфинктере, что ведет к росту внутрипротокового давления и, как следствие, возникновению билиарной либо панкреатической боли. Кроме того, из-за механического нарушения иннервации изменяются непосредственные сократительные эффекты влияния холецистокинина на гладкую мускулатуру желчевыводящих путей. Гипертензия панкреатической части сфинктера Одди может обусловливать не только возникновение функциональной боли панкреатического типа, но и развитие рецидивирующего панкреатита. Типичными для ДСО являются анамнестические данные, характерные для функциональной патологии пищеварительной системы, такие как длительность симптоматики, отсутствие органической патологии, множественные жалобы, непрогрессирующее течение, провоцирующая роль психоэмоциональных факторов. С практической точки зрения клиническими критериями ДСО могут служить: 1) приступ билиарной или панкреатической боли; 2) транзиторное повышение активности печеночных или панкреатических ферментов; 3) транзиторное расширение общего желчного или главного панкреатического протока. В случае затрудненного дифференциального диагноза целесообразно эндоскопическое ультразвуковое исследование. Основу лечения составляют спазмолитические средства и урсодезоксихолевая кислота, особенно при выявлении билиарного сладжа и микролитиаза. Показания к хирургическому лечению должны иметь веское обоснование.</p></abstract><trans-abstract xml:lang="en"><p>The persistent post-cholecystectomy (CE) symptoms can be divided into four groups: 1) surgical errors; 2) recurrence of cholelithiasis; 3) functional disorders due to removal of the gallbladder (transient or persistent); 4) pathology not associated with CE. Biliary pain persists in 20–40% of patients after CE, in most cases caused by sphincter of Oddi dysfunction (SOD). SOD is subdivided into biliary, pancreatic, two-duct types, as well as pancreatobiliary reflux. The SOD is rooted in the increased pressure in the sphincter, which leads to the increased intraductal pressure and, as a result, to the occurrence of biliary or pancreatic pain. In addition, the direct contractile effects of cholecystokinin on smooth muscles of the biliary tract change due to mechanical disturbance of innervation. Hypertension of the pancreatic part of the sphincter of Oddi can cause not only the occurrence of functional pain of the pancreatic type, but also the development of recurrent pancreatitis. SOD is characterized by typical anamnestic data that are common to the functional pathology of the digestive system, such as duration of symptoms, absence of organic pathology, multiple complaints, a non-progressive course, the provoking role of psychoemotional factors. From a practical standpoint, the clinical criteria for SOD can be: 1) an attack of biliary or pancreatic pain; 2) a transient increase in the activity of hepatic or pancreatic enzymes; 3) transient expansion of the common bile or major pancreatic duct. If it is difficult to differentiate diagnosis, endoscopic ultrasonography is advisable. Antispasmodics and ursodeoxycholic acid form the basis of the treatment, especially when biliary sludge and microlithiasis are detected. There must be strong arguments for the surgical treatment.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>холецистэктомия</kwd><kwd>абдоминальная боль</kwd><kwd>дисфункция сфинктера Одди</kwd><kwd>диагностика</kwd><kwd>лечение</kwd></kwd-group><kwd-group xml:lang="en"><kwd>cholecystectomy</kwd><kwd>abdominal pain</kwd><kwd>sphincter of Oddi dysfunction</kwd><kwd>diagnosis</kwd><kwd>treatment</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Ильченко А.А. Болезни желчного пузыря и желчных путей: руководство для врачей. 2-е изд. М.: МИА; 2011. 880 с. Режим доступа: https://docplayer.ru/43313625-Bolezni-zhelchnogo-puzyrya-i-zhelchnyh-putey.html.Ilchenko</mixed-citation><mixed-citation xml:lang="en">A.A. Gallbladder and bile duct diseases: guidelines for physicians. 2nd ed. Мoscow: MIA; 2011. 880 p. (In Russ.) Available at: https://docplayer.ru/43313625-Bolezni-zhelchnogo-puzyrya-i-zhelchnyh-putey.html.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Bielefeldt K., Saligram S., Zickmund S.L., Dudekula A., Olyaee M., Yadav D. Cholecystectomy for biliary dyskinesia: how did we get there? Dig Dis Sci. 2014;59:2850–2863. doi: 10.1007/s10620-014-3342-9.</mixed-citation><mixed-citation xml:lang="en">Bielefeldt K., Saligram S., Zickmund S.L., Dudekula A., Olyaee M., Yadav D. Cholecystectomy for biliary dyskinesia: how did we get there? Dig Dis Sci. 2014;59:2850–2863. doi: 10.1007/s10620-014-3342-9.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Cotton P.B., Elta G.H., Carter C.R., Pasricha P.J., Corazziari E.S. Rome IV. Gallbladder and Sphincter of Oddi Disorders. Gastroenterology. 2016;150(6):1420–1429. doi: 10.1053/j.gastro.2016.02.033.</mixed-citation><mixed-citation xml:lang="en">Cotton P.B., Elta G.H., Carter C.R., Pasricha P.J., Corazziari E.S. Rome IV. Gallbladder and Sphincter of Oddi Disorders. Gastroenterology. 2016;150(6):1420–1429. doi: 10.1053/j.gastro.2016.02.033.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Latenstein C.S.S., Wennmacker S.Z., de Jong J.J., van Laarhoven C.J.H.M., Drenth J.P.H., de Reuver P.R. Etiologies of Long-Term Postcholecystectomy Symptoms: A Systematic Review. Gastroenterol Res Pract. 2019;14:4278373. doi: 10.1155/2019/4278373.</mixed-citation><mixed-citation xml:lang="en">Latenstein C.S.S., Wennmacker S.Z., de Jong J.J., van Laarhoven C.J.H.M., Drenth J.P.H., de Reuver P.R. Etiologies of Long-Term Postcholecystectomy Symptoms: A Systematic Review. Gastroenterol Res Pract. 2019;14:4278373. doi: 10.1155/2019/4278373.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Isherwood J., Oakland K., Khanna A. A systematic review of the aetiology and management of post cholecystectomy syndrome. Surgeon. 2019;17(1):33–42. doi: 10.1016/j.surge.2018.04.001.</mixed-citation><mixed-citation xml:lang="en">Isherwood J., Oakland K., Khanna A. A systematic review of the aetiology and management of post cholecystectomy syndrome. Surgeon. 2019;17(1):33–42. doi: 10.1016/j.surge.2018.04.001.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Мехтиев С.Н., Мехтиева О.А., Куликова Ю.Р. Функциональные расстройства сфинктера Одди в практике терапевта. Лечащий врач. 2017;(9). Режим доступа: https://www.lvrach.ru/2017/9/15436812.</mixed-citation><mixed-citation xml:lang="en">Mekhtiev S.N., Mekhtieva O.A., Kulikova Yu.R. Oddi’s sphincter functional disorders in therapeutic practice. Lechashchiy vrach = Attending Doctor. 2017;(9). (In Russ.) Available at: https://www.lvrach.ru/2017/9/15436812.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Hofeldt M., Richmond B., Huffman K., Nestor J., Maxwell D. Laparoscopic cholecystectomy for treatment of biliary dyskinesia is safe and effective in the pediatric population. Am Surg. 2008;74(11):1069–1072. Available at: https://pubmed.ncbi.nlm.nih.gov/19062663/</mixed-citation><mixed-citation xml:lang="en">Hofeldt M., Richmond B., Huffman K., Nestor J., Maxwell D. Laparoscopic cholecystectomy for treatment of biliary dyskinesia is safe and effective in the pediatric population. Am Surg. 2008;74(11):1069–1072. Available at: https://pubmed.ncbi.nlm.nih.gov/19062663/</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Miyatani H., Mashima H., Sekine M., Matsumoto S. Clinical course of biliary-type sphincter of Oddi dysfunction: endoscopic sphincterotomy and functional dyspepsia as affecting factors. Ther Adv Gastrointest Endosc. 2019;12:2631774519867184. doi: 10.1177/2631774519867184.</mixed-citation><mixed-citation xml:lang="en">Miyatani H., Mashima H., Sekine M., Matsumoto S. Clinical course of biliary-type sphincter of Oddi dysfunction: endoscopic sphincterotomy and functional dyspepsia as affecting factors. Ther Adv Gastrointest Endosc. 2019;12:2631774519867184. doi: 10.1177/2631774519867184.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Thune A., Saccone G.T., Scicchitano J.P., Toouli J. Distension of the gall bladder inhibits sphincter of Oddi motility in humans. Gut. 1991;32(6):690–693. doi: 10.1136/gut.32.6.690.</mixed-citation><mixed-citation xml:lang="en">Thune A., Saccone G.T., Scicchitano J.P., Toouli J. Distension of the gall bladder inhibits sphincter of Oddi motility in humans. Gut. 1991;32(6):690–693. doi: 10.1136/gut.32.6.690.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Middelfart H.V., Matzen P., Funch-Jensen P. Sphincter of Oddi manometry before and after laparoscopic cholecystectomy. Endoscopy. 1999;31(2):146–151. doi: 10.1055/s-1999-13663.</mixed-citation><mixed-citation xml:lang="en">Middelfart H.V., Matzen P., Funch-Jensen P. Sphincter of Oddi manometry before and after laparoscopic cholecystectomy. Endoscopy. 1999;31(2):146–151. doi: 10.1055/s-1999-13663.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Pariente A., Berthelemy P., Arotcarena R. The underestimated role of opiates in sphincter of Oddi dysfunction. Gastroenterology. 2013;144(7):1571. doi: 10.1053/j.gastro.2013.03.056.</mixed-citation><mixed-citation xml:lang="en">Pariente A., Berthelemy P., Arotcarena R. The underestimated role of opiates in sphincter of Oddi dysfunction. Gastroenterology. 2013;144(7):1571. doi: 10.1053/j.gastro.2013.03.056.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Cotton P.B., Durkalski V., Romagnuolo J., Pauls Q., Fogel E., Tarnasky P. et al. Effect of endoscopic sphincterotomy for suspected sphincter of Oddi dysfunction on pain-related disability following cholecystectomy: the EPISOD randomized clinical trial. JAMA. 2014;311(20):2101–2109. doi: 10.1001/jama.2014.5220.</mixed-citation><mixed-citation xml:lang="en">Cotton P.B., Durkalski V., Romagnuolo J., Pauls Q., Fogel E., Tarnasky P. et al. Effect of endoscopic sphincterotomy for suspected sphincter of Oddi dysfunction on pain-related disability following cholecystectomy: the EPISOD randomized clinical trial. JAMA. 2014;311(20):2101–2109. doi: 10.1001/jama.2014.5220.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Senturk S., Miroglu T.C., Bilici A., Gumus H. Diameters of the common bile duct in adults and postcholecystectomy patients: a study with 64-slice CT. Eur J Radiol. 2012;81(1):39–42. doi: 10.1016/j.ejrad.2010.11.007.</mixed-citation><mixed-citation xml:lang="en">Senturk S., Miroglu T.C., Bilici A., Gumus H. Diameters of the common bile duct in adults and postcholecystectomy patients: a study with 64-slice CT. Eur J Radiol. 2012;81(1):39–42. doi: 10.1016/j.ejrad.2010.11.007.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Mazaki T., Mado K., Masuda H., Shiono M. Prophylactic pancreatic stent placement and post-ERCP pancreatitis: an updated meta-analysis. J Gastroenterol. 2014;49:343–355. doi: 10.1007/s00535-013-0806-1.</mixed-citation><mixed-citation xml:lang="en">Mazaki T., Mado K., Masuda H., Shiono M. Prophylactic pancreatic stent placement and post-ERCP pancreatitis: an updated meta-analysis. J Gastroenterol. 2014;49:343–355. doi: 10.1007/s00535-013-0806-1.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Akshintala V.S., Hutfless S.M., Colantuoni E., Kim K.J., Khashab M.A., Elmunzer B.J. et al. Systematic review with network meta-analysis: pharmacological prophylaxis against post-ERCP pancreatitis. Aliment Pharmacol Ther. 2013;38(11-12):1325–1337. doi: 10.1111/apt.12534.</mixed-citation><mixed-citation xml:lang="en">Akshintala V.S., Hutfless S.M., Colantuoni E., Kim K.J., Khashab M.A., Elmunzer B.J. et al. Systematic review with network meta-analysis: pharmacological prophylaxis against post-ERCP pancreatitis. Aliment Pharmacol Ther. 2013;38(11-12):1325–1337. doi: 10.1111/apt.12534.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Vitton V., Delpy R., Gasmi M., Lesavre N., Abou-Berdugo E., Desjeux A. et al. Is endoscopic sphincterotomy avoidable in patients with sphincter of Oddi dysfunction? Eur J Gastroenterol Hepatol. 2008;20(1):15–21. doi: 10.1097/MEG.0b013e3282eeb4a1.</mixed-citation><mixed-citation xml:lang="en">Vitton V., Delpy R., Gasmi M., Lesavre N., Abou-Berdugo E., Desjeux A. et al. Is endoscopic sphincterotomy avoidable in patients with sphincter of Oddi dysfunction? Eur J Gastroenterol Hepatol. 2008;20(1):15–21. doi: 10.1097/MEG.0b013e3282eeb4a1.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Nakeeb A. Sphincter of Oddi dysfunction: how is it diagnosed? How is it classified? How do we treat it medically, endoscopically, and surgically? J Gastrointest. Surg. 2013;17(9):1557–1558. doi: 10.1007/s11605-013-2280-8.</mixed-citation><mixed-citation xml:lang="en">Nakeeb A. Sphincter of Oddi dysfunction: how is it diagnosed? How is it classified? How do we treat it medically, endoscopically, and surgically? J Gastrointest. Surg. 2013;17(9):1557–1558. doi: 10.1007/s11605-013-2280-8.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Wu Q., Cotton P.B., Durkalski V. et al. Duloxetine for the treatment of patients with suspected sphincter of Oddi dysfunction: an open-label pilot study. Gastrointest Endosc. 2011;73(Suppl):AB189.</mixed-citation><mixed-citation xml:lang="en">Wu Q., Cotton P.B., Durkalski V. et al. Duloxetine for the treatment of patients with suspected sphincter of Oddi dysfunction: an open-label pilot study. Gastrointest Endosc. 2011;73(Suppl):AB189.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Guelrud M., Rossiter A., Souney P.F., Mendoza S., Mijica V. The effect of transcutaneous nerve stimulation on sphincter of Oddi pressure in patients with biliary dyskinesia. Am J Gastroenterol. 1991;86(5):581–585. Available at: https://pubmed.ncbi.nlm.nih.gov/2028948/</mixed-citation><mixed-citation xml:lang="en">Guelrud M., Rossiter A., Souney P.F., Mendoza S., Mijica V. The effect of transcutaneous nerve stimulation on sphincter of Oddi pressure in patients with biliary dyskinesia. Am J Gastroenterol. 1991;86(5):581–585. Available at: https://pubmed.ncbi.nlm.nih.gov/2028948/</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Lee S.K., Kim M.H., Kim H.J., Seo D.W., Yoo K.S., Joo Y.H. et al. Electroacupuncture may relax the sphincter of Oddi in humans. Gastrointest Endosc. 2001;53(2):211–216. doi: 10.1067/mge.2001.112180.</mixed-citation><mixed-citation xml:lang="en">Lee S.K., Kim M.H., Kim H.J., Seo D.W., Yoo K.S., Joo Y.H. et al. Electroacupuncture may relax the sphincter of Oddi in humans. Gastrointest Endosc. 2001;53(2):211–216. doi: 10.1067/mge.2001.112180.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Bakman Y., Freeman M.L., Martin L. Update on biliary and pancreatic sphincterotomy. Curr Opin Gastroenterol. 2012;28(5):420–426. doi: 10.1097/MOG.0b013e32835672f3.</mixed-citation><mixed-citation xml:lang="en">Bakman Y., Freeman M.L., Martin L. Update on biliary and pancreatic sphincterotomy. Curr Opin Gastroenterol. 2012;28(5):420–426. doi: 10.1097/MOG.0b013e32835672f3.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Cotton P.B., Pauls Q., Keith J., Thornhill A., Drossman D., Williams A., Durkalski-Mauldin V. The EPISOD study: long-term outcomes. Gastrointest Endosc. 2018;87(1):205–210. doi: 10.1016/j.gie.2017.04.015.</mixed-citation><mixed-citation xml:lang="en">Cotton P.B., Pauls Q., Keith J., Thornhill A., Drossman D., Williams A., Durkalski-Mauldin V. The EPISOD study: long-term outcomes. Gastrointest Endosc. 2018;87(1):205–210. doi: 10.1016/j.gie.2017.04.015.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Wehrmann T., Seifert H., Seipp M., Lembcke B., Caspary W.F. Endoscopic injection of botulinum toxin for biliary sphincter of Oddi dysfunction. Endoscopy. 1998;30(8):702–707. doi: 10.1055/s-2007-1001392.</mixed-citation><mixed-citation xml:lang="en">Wehrmann T., Seifert H., Seipp M., Lembcke B., Caspary W.F. Endoscopic injection of botulinum toxin for biliary sphincter of Oddi dysfunction. Endoscopy. 1998;30(8):702–707. doi: 10.1055/s-2007-1001392.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Cariati M., Chiarello M.M., Cannistra M., Lerose M.A., Brisinda G. Gastrointestinal Uses of Botulinum Toxin. In: Handbook Exp Pharmacol. Springer, Berlin, Heidelberg; 2019. doi: 10.1007/164_2019_326.</mixed-citation><mixed-citation xml:lang="en">Cariati M., Chiarello M.M., Cannistra M., Lerose M.A., Brisinda G. Gastrointestinal Uses of Botulinum Toxin. In: Handbook Exp Pharmacol. Springer, Berlin, Heidelberg; 2019. doi: 10.1007/164_2019_326.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Sherman S., Lehman G., Jamidar P. Efficacy of endoscopic sphincterotomy and surgical sphincteroplasty for patients with sphincter of Oddi dysfunction (SOD); randomized, controlled study. Gastrointest Endosc. 1994;40125.</mixed-citation><mixed-citation xml:lang="en">Sherman S., Lehman G., Jamidar P. Efficacy of endoscopic sphincterotomy and surgical sphincteroplasty for patients with sphincter of Oddi dysfunction (SOD); randomized, controlled study. Gastrointest Endosc. 1994;40125.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Toouli J., Roberts-Thomson I.C., Kellow J., Dowsett J., Saccone G.T.P., Evans P. et al. Manometry based randomised trial of endoscopic sphincterotomy for sphincter of Oddi dysfunction. Gut. 2000;46(1):98–102. doi: 10.1136/gut.46.1.98.</mixed-citation><mixed-citation xml:lang="en">Toouli J., Roberts-Thomson I.C., Kellow J., Dowsett J., Saccone G.T.P., Evans P. et al. Manometry based randomised trial of endoscopic sphincterotomy for sphincter of Oddi dysfunction. Gut. 2000;46(1):98–102. doi: 10.1136/gut.46.1.98.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Heetun Z.S., Zeb F., Cullen G., Courtney G., Aftab A.R. Biliary sphincter of Oddi dysfunction: response rates after ERCP and sphincterotomy in a 5-year ERCP series and proposal for new practical guidelines. Eur J Gastroenterol Hepatol. 2011;23(4):327–333. doi: 10.1097/MEG.0b013e3283433aa1.</mixed-citation><mixed-citation xml:lang="en">Heetun Z.S., Zeb F., Cullen G., Courtney G., Aftab A.R. Biliary sphincter of Oddi dysfunction: response rates after ERCP and sphincterotomy in a 5-year ERCP series and proposal for new practical guidelines. Eur J Gastroenterol Hepatol. 2011;23(4):327–333. doi: 10.1097/MEG.0b013e3283433aa1.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Choudhry U., Ruffolo T., Jamidar P., Hawes R., Lehman G. Sphincter of Oddi dysfunction in patients with intact gallbladder: therapeutic response to endoscopic sphincterotomy. Gastrointest Endosc. 1993;39(4):492–495. doi: 10.1016/s0016-5107(93)70157-1.</mixed-citation><mixed-citation xml:lang="en">Choudhry U., Ruffolo T., Jamidar P., Hawes R., Lehman G. Sphincter of Oddi dysfunction in patients with intact gallbladder: therapeutic response to endoscopic sphincterotomy. Gastrointest Endosc. 1993;39(4):492–495. doi: 10.1016/s0016-5107(93)70157-1.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
